In a KRAS-driven mouse model of pancreatic ductal adenocarcinoma, hypoxia results in B-cell exclusion, and it is speculated that the underlying mechanism is that in a hypoxic environment, KRAS mutation results in the exclusion of immune cells via hypoxia-inducible factor-1 122. This evidence concerns the gene KRAS and pancreatic ductal adenocarcinoma.